The Animal Healthcare Market is expected to grow on a healthy note further. The current scenario is such that virtual monitoring tools are being called for. They act as a precision factor for the healthcare vertical. With the turning out to be more accessible for patients and providers alike, several post-operative intervention options are being made available for preventing hospital re-admittance and complications. With cost-effectiveness rendered as well, the healthcare vertical is expected to take off on a flourishing note going forward.
The Animal Healthcare Market taught to grow sporadically shortly. With improvement in machine-powered analytics, the healthcare vertical is bound to substantiate therein. Machine learning does make caregivers able of putting data to use, thereby enhancing patients’ outcomes along with overall efficiency. This would be the trend in the healthcare vertical going forward.
Major factor boosting demand for animal healthcare is industrialization of the dairy and meat industry across the world. Moreover, rising zoonotic and foodborne diseases and increasing trend of pet adoption are additionally complementing market expansion.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/2882
According to a revised report published by Persistence Market Research, the global animal healthcare market was valued at US$ 36.1 Bn in 2020, and is predicted to expand at a CAGR of more than 4% over the forecast period (2021-2031).
Company Profiles:
- Bayer AG
- BoehringerIngelheim GmbH
- Virbac SA
- Zoetis, Inc.
- Hester Biosciences Ltd.
- Intas Pharmaceuticals Ltd.
- Merck Animal Health
- Elanco (Eli Lilly and Company)
- Ceva Santé Animale
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/2882
Get a Customized Scope to Match Your Need Ask an Expert- [email protected]
Key Takeaways from Market Study
- Parasiticides are expected to contribute around 27% revenue share in the market by 2031, owing to increasing preference for animal care and hygiene.
- Farm animals are expected to account for more than half of the global market share. Industrialization of the dairy and meat industry has led to increasing demand for animal-based products, adding to the market development.
- Oral route of administration in animal healthcare is expected to contribute around 45% revenue share in the market by 2031, as it gives the highest level of drug stability and accurate measurements.
- Among all the distribution channels, veterinary hospitals accounted for more than 35% of the market share in 2020. Different applications such as clinical toxicology tests, therapy, and clinical pathology will boost market expansion.
- North America holds the highest share in the global market for animal healthcare, owing to the presence of big market players, high healthcare expenditure, and growing research & development efforts in the country.
- Key players are focused on strengthening their clinical pipelines with discoveries of novel abuse-deterrent formulations and also through various acquisitions.
- The market in the U.S. holds a big portion of global revenue at 30%, and accounts for more than 85% share in the North American market.
“Increase in incidence of infectious disease transmission in animals, growth in animal inhabitants, and rising adoption of companion animals are factors driving market growth,” says an analyst at Persistence Market Research.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/2882
Increased Funding & Support from International Organizations
International agencies such as U.K. Science have made major contributions toward global eradication of rinderpest diseases, and this has a major impact on controlling FMD and Peste des Petits in ruminants.
Other funding programs are often supported by the WHO, country-specific governments, and private humanitarian agencies. Stakeholders identify the need to prevent economic losses arising due to lack of effective vaccinations and instead take a proactive preventive dimension for animal healthcare.
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the animal healthcare market in its latest study, presenting a historical demand assessment of 2016 – 2020 and projections for 2021 – 2031. The research study is based on drug (anti-infective agents, anti-inflammatory & analgesic agents, parasiticides, vaccines, hormones & substitutes, nutritional products, and others), animal (companion animals and farm animals), route of administration (oral, parenteral, topical, and others) and distribution channel (veterinary hospital, veterinary clinics, pharmacies and drug stores, and others), across seven key regions of the world.
About us: Persistence Market Research
Contact us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
